Skip Ribbon Commands
Skip to main content

Our Expertise

ISO accredited assays

We provide ISO 15189-accredited assays to assess outcomes of early phase clinical trials.

Guided screening of vaccine/therapeutic candidates

We generate deep data to guide down-selection of vaccine/therapeutic candidates to avoid late-stage failures.

Translational research solutions

We support bench to bedside translation of infectious disease therapeutics and vaccines in a timely and affordable manner.

Proposed design of our trials: We analyse deep data, such as transcriptomics, metabolomics and proteomics, to study correlates of adverse events and immunogenicity. Together with analysis of humoral and cellular responses we are able to build a network of information pertaining to the performance of vaccine or therapeutic interventions. (Image created with

Notable Clinical Trials

  • NCT04906980 – Janssen Research & Development, LLC
    Safety, Tolerability and Pharmacokinetics of a DENV Inhibitor in Participants With Confirmed Dengue Fever.
  • NCT04490857 – Arcturus Therapeutics
    Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects.
  • NCT04429529 – Tychan Pte Ltd
    Safety of TY027, a Treatment for COVID-19, in Adults.
  • NCT03746015 – Takeda Vaccines
    Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults.
  • NCT03776786 – Tychan Pte Ltd
    Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Adults.
  • NCT04728347 – Arcturus Therapeutics
    Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021.
  • NCT01943305 – Investigator initiated trial
    The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Adults.
  • NCT04267809 – Investigator initiated trial
    Modulating Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection.
    For more information on our expertise and services, click here.